Received Jun 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 4L454 | IM / LL |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 2 | Y018703 | SC / RL |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 2 | Z003767 | SC / LL |
Within about 15 minutes of receiving the vaccine, as he was in the parking lot leaving clinic, the patient had an episode of vomiting, which was originally thought to be related to crying and emotional distress about the vaccinations. He then fell asleep in the car on the way home, which is very atypical for him. When he got home about 30 minutes later (45 minutes after receiving the vaccine) his parent noted scattered large areas of confluent erythematous rash involving the extremities, torso, and face. He also developed periorbital swelling, eye redness, and itchy eyes. A dose of Benadryl was given, and rash resolved. He was able to eat a normal dinner that night and slept well. In the morning he still had residual periorbital swelling and eyes were still injected. He never had any respiratory symptoms, and his physical exam at 10am the morning after the episode was notable only for periorbital swelling, conjunctival injection, and a few excoriations on the lower abdomen.
Mild URI symptoms (runny nose and congestion) a few days prior to the vaccine
Tetralogy of Fallot
None
None
He has been referral to Pediatric Allergy clinic for additional testing.